Innoviva (INVA) Return on Sales (2011 - 2026)

Innoviva (INVA) posted Return on Sales of 0.02% for Q1 2026, up 112.09% on a QoQ basis from 0.16% in Q4 2025, and up 2.0% year-over-year from 0.02% in Q1 2025.

Innoviva (INVA) Return on Sales (2011 - 2026) Analysis & Trends

Innoviva's Return on Sales history runs 16 years deep, the most recent figure standing at 0.02% for Q1 2026.

  • Quarterly Return on Sales rose 2.0% year-over-year to 0.02% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.01% (up 1.0% YoY) and the FY2025 annual result came in at 0.01%, up 1.0% from the prior year.
  • Return on Sales was 0.02% for Q1 2026 at Innoviva, up from 0.16% in the prior quarter.
  • Across five years, Return on Sales topped out at 0.19% in Q1 2023 and bottomed at 1.15% in Q4 2023.
  • A 5-year average of 0.06% and a median of 0.0% in 2023 frame the typical range for Return on Sales.
  • Annual changes were most pronounced in 2023 — Return on Sales tumbled 100 bps — and 2024, when it soared 102 bps.
  • Innoviva's Return on Sales stood at 0.15% in 2022, then slumped by 660 bps to 1.15% in 2023, then jumped by 89 bps to 0.13% in 2024, then retreated by 25 bps to 0.16% in 2025, then surged by 112 bps to 0.02% in 2026.
  • Business Quant data shows INVA's Return on Sales at 0.02% in Q1 2026, 0.16% in Q4 2025, and 0.0% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 0.00%
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 0.00%
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 0.00%
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 0.00%
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Innoviva 1.57 Bn 969.11 Mn 75.83 Mn 0.02%

Historic Data

Download Data
DateValue
Mar 31, 2026 0.02%
Dec 31, 2025 -0.16%
Sep 30, 2025 0.00%
Jun 30, 2025 0.01%
Mar 31, 2025 -0.01%
Dec 31, 2024 -0.13%
Sep 30, 2024 0.00%
Jun 30, 2024 0.00%
Mar 31, 2024 0.15%
Dec 31, 2023 -1.15%
Sep 30, 2023 0.01%
Jun 30, 2023 0.00%
Mar 31, 2023 0.19%
Dec 31, 2022 -0.15%
Sep 30, 2022 0.01%
Jun 30, 2022 0.05%
Mar 31, 2022 0.17%
Dec 31, 2021 -0.45%
Sep 30, 2021 0.01%
Jun 30, 2021 0.40%